Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2016 June;64(3) > Minerva Cardioangiologica 2016 June;64(3):284-94

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

REVIEWS  CONTEMPORARY ISSUES RELATED TO STEMI MANAGEMENT


Minerva Cardioangiologica 2016 June;64(3):284-94

language: English

Promising strategies to minimize reperfusion injury in STEMI

Heerajnarain BULLUCK, Robert L. YELLON, Derek M. YELLON

The Hatter Cardiovascular Institute, University College London, London, UK


PDF  


Morbidity in patients presenting with acute ST-segment elevation myocardial infarction remains significant despite prompt reperfusion by primary percutaneous coronary intervention. This has been partly attributed to “myocardial reperfusion injury” whereby the process of restoring coronary blood flow paradoxically induces myocardial injury and cardiomyocyte death, mitigating the full beneficial effects of reperfusion. A large number of cardioprotective therapies to reduce myocardial infarct size have been investigated in preclinical and small proof-of-concept clinical studies with mixed results. In this article, we provide an overview of the most promising cardioprotective therapies for reducing myocardial infarct size that warrant further investigation in outcome studies.

top of page

Publication History

Cite this article as

Corresponding author e-mail

d.yellon@ucl.ac.uk